Ajanta Pharma was up 5.63% to Rs 931 at 12:29 IST on the BSE after consolidated net profit rose 8.4% to Rs 114.63 crore on 19.8% rise in net sales to Rs 611.94 crore in Q1 June 2019 over Q1 June 2018.
The result was announced after market hours yesterday, 31 July 2019.
Meanwhile, the S&P BSE Sensex was down by 422.92 points or 1.13% to 37,058.83.
On the BSE, 38000 shares were traded in the counter so far compared with average daily volumes of 3536 shares in the past two weeks. The stock had hit a high of Rs 932.4 and a low of Rs 881.55 so far during the day. The stock hit a 52-week high of Rs 1294.1 on 5 September 2018 and a 52-week low of Rs 840 on 31 July 2019.
Earnings before interest tax depreciation and amortization (EBITDA) increased 7% to Rs 168 crore in Q1 June 2019 over Q1 June 2018.
Total exports grew 25% to Rs 404 crore in Q1 June 2019 from Rs 324 crore in Q1 June 2018.
Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India, USA and emerging markets.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app